Company News, People News

Del Laboratories: William McMenemy

Author Image

By: TOM BRANNA

Editor

Del Laboratories: Following the acquisition of Del by DLI Holding Corp. later this year, Dan K. Wassong will retire. William McMenemy, currently executive vice president of marketing at Del will become president and chief executive officer. Charles J. Hinkaty, vice president of Del and president of Del Pharmaceuticals, will become chief operating officer. Harvey Alstodt, currently executive vice president of sales, will become president of global business. Enzo J. Vialardi will remain executive ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters